Costs of parkinson. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Substantia Nigra Lewy Bodies Dopaminergic Neurons Subthalamic Nucleus Putamen Neurons Brain Pedunculopontine Tegmental Nucleus Corpus Striatum Globus Pallidus Mesencephalon Mitochondria Basal Ganglia Neostriatum Inclusion Bodies PC12 Cells Caudate Nucleus

Diseases31

Parkinson Disease Parkinsonian Disorders Parkinson Disease, Secondary Multiple System Atrophy Lewy Body Disease Neurodegenerative Diseases Gait Disorders, Neurologic MPTP Poisoning Supranuclear Palsy, Progressive Essential Tremor REM Sleep Behavior Disorder Gaucher Disease Dementia Nerve Degeneration Hypokinesia Movement Disorders Genetic Predisposition to Disease Dyskinesias Olfaction Disorders Disease Models, Animal Alzheimer Disease Sleep Arousal Disorders Primary Dysautonomias Postmortem Changes Manganese Poisoning Dyskinesia, Drug-Induced Pure Autonomic Failure Deglutition Disorders Sweat Gland Diseases Parkinson Disease, Postencephalitic Disease Progression

Chemicals and Drugs53

alpha-Synuclein Antiparkinson Agents Levodopa Glucosylceramidase Dopamine 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Oxidopamine Ubiquitin-Protein Ligases Oncogene Proteins Tyrosine 3-Monooxygenase Pergolide Carbidopa beta-Synuclein Maneb Neuroprotective Agents 1-Methyl-4-phenylpyridinium Synucleins Tropanes Dopamine Plasma Membrane Transport Proteins Dopamine Agents Dopamine Agonists Benzothiazoles tau Proteins Rotenone Adrenergic Agents Paraquat Apomorphine Amyloid Sympatholytics Nerve Tissue Proteins Pemoline Selenoprotein W Receptors, Dopamine 3,4-Dihydroxyphenylacetic Acid Intracellular Signaling Peptides and Proteins Protein-Serine-Threonine Kinases Chromogranin B Vesicular Monoamine Transport Proteins Cysteinyldopa Proteasome Endopeptidase Complex Ubiquitin Sodium Benzoate Dihydroxyphenylalanine Herbicides Protein Kinases Fungicides, Industrial Selegiline Electron Transport Complex I Thiazoles Amyloid beta-Peptides Glial Cell Line-Derived Neurotrophic Factor Neurotoxins Monoamine Oxidase

Analytical, Diagnostic and Therapeutic Techniques and Equipment39

Deep Brain Stimulation Dance Therapy Models, Economic Gait Quality-Adjusted Life Years Severity of Illness Index Case-Control Studies Disease Models, Animal Treatment Outcome Genetic Testing Retrospective Studies Positron-Emission Tomography Cohort Studies Reproducibility of Results Sensitivity and Specificity Genome-Wide Association Study Prospective Studies Models, Biological Analysis of Variance Risk Factors Neurologic Examination Stereotaxic Techniques Follow-Up Studies Hospitalization Questionnaires Length of Stay DNA Mutational Analysis Exercise Therapy Disability Evaluation Activities of Daily Living Physical Therapy Modalities Markov Chains Ambulatory Care Risk Assessment Magnetic Resonance Imaging Autopsy Predictive Value of Tests Pilot Projects Incidence

Psychiatry and Psychology20

Lewy Body Disease Dance Therapy REM Sleep Behavior Disorder Dementia Neuropsychological Tests Alzheimer Disease Apathy Sleep Arousal Disorders Cognition Disorders Motor Skills Efficiency Dreams Reality Therapy Mental Status Schedule Introversion (Psychology)Task Performance and Analysis Impulse Control Disorders Psychomotor Performance Motor Activity Cognition

Phenomena and Processes22

Postural Balance Gait Mutation Genetic Predisposition to Disease Time Factors Autophagy Sensitivity and Specificity Polymorphism, Single Nucleotide Oxidative Stress Penetrance Genotype Movement Mutation, Missense Mitochondrial Degradation DNA Repeat Expansion Walking Psychomotor Performance Motor Activity Markov Chains Proteolysis Decision Trees Locomotion

Disciplines and Occupations1

Anthropology, Education, Sociology and Social Phenomena5

Cost of Illness Quality of Life Activities of Daily Living Walking Autopsy

Humanities1

Quality of Life

Information Science3

Quality-Adjusted Life Years Questionnaires Incidence

Health Care45

Health Care Costs Costs and Cost Analysis Drug Costs Cost of Illness Cost Control Direct Service Costs Cost Sharing Cost-Benefit Analysis Cost Allocation Models, Economic Employer Health Costs Quality-Adjusted Life Years Severity of Illness Index Age of Onset Case-Control Studies Treatment Outcome Genetic Testing Retrospective Studies Cohort Studies Health Resources Reproducibility of Results Sensitivity and Specificity Genome-Wide Association Study Prospective Studies Analysis of Variance Accidental Falls Risk Factors Follow-Up Studies Hospitalization Managed Care Programs Questionnaires Length of Stay Insurance Claim Review Age Factors Activities of Daily Living Markov Chains Family Health Ambulatory Care Risk Assessment Predictive Value of Tests Budgets Pilot Projects Fees, Pharmaceutical Incidence Financing, Personal

Geographicals2

United States Guadeloupe

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care Geographicals

Parkinson Disease Health Care Costs Costs and Cost Analysis Drug Costs Cost of Illness alpha-Synuclein Antiparkinson Agents Parkinsonian Disorders Cost Control Parkinson Disease, Secondary Levodopa Direct Service Costs Glucosylceramidase Cost Sharing Cost-Benefit Analysis Substantia Nigra Lewy Bodies Cost Allocation Deep Brain Stimulation Multiple System Atrophy Dopamine 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Dopaminergic Neurons Oxidopamine Subthalamic Nucleus Lewy Body Disease Neurodegenerative Diseases Gait Disorders, Neurologic MPTP Poisoning Supranuclear Palsy, Progressive Postural Balance Dance Therapy Putamen Essential Tremor Ubiquitin-Protein Ligases Models, Economic Gait Neurons Brain Pedunculopontine Tegmental Nucleus REM Sleep Behavior Disorder Gaucher Disease Oncogene Proteins Tyrosine 3-Monooxygenase Pergolide Carbidopa Employer Health Costs Dementia United States Nerve Degeneration Hypokinesia Quality-Adjusted Life Years beta-Synuclein Corpus Striatum Severity of Illness Index Mutation Movement Disorders Globus Pallidus Mesencephalon Genetic Predisposition to Disease Age of Onset Maneb Neuroprotective Agents Mitochondria Case-Control Studies Dyskinesias Neuropsychological Tests 1-Methyl-4-phenylpyridinium Olfaction Disorders Synucleins Tropanes Time Factors Disease Models, Animal Dopamine Plasma Membrane Transport Proteins Treatment Outcome Dopamine Agents Genetic Testing Retrospective Studies Positron-Emission Tomography Alzheimer Disease Dopamine Agonists Apathy Cohort Studies Benzothiazoles Health Resources Sleep Arousal Disorders Reproducibility of Results Autophagy tau Proteins Primary Dysautonomias Rotenone Cognition Disorders Adrenergic Agents Postmortem Changes Sensitivity and Specificity Genome-Wide Association Study Prospective Studies Basal Ganglia Models, Biological Manganese Poisoning

No FAQ available that match "costs of parkinson"